Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Pretty much every company you can think of has donated to the Clinton Foundation. So has Donald Trump. Should it matter?
The recent harsh spotlight on the sector raises the question.
Wall Street will look to comments from Fed Chair Janet Yellen on interest rates; futures are higher; Carl Icahn recently discussed selling his stake in Herbalife, a report says.